A Currently concluded research study based on the large health insurance database revealed that people who’d suffered sudden deafness were more probable to have a previous diagnosis of sleep apnea than a comparison group without hearing loss.

Taiwanese health insurance data analysis revealed that the absolute difference is actually small: 1.7 percent of those with hearing loss had sleep apnea in comparison to 1.2 percent without hearing trouble.

The health records of nearly one million Taiwanese evaluated by Dr. Jau-Jiuan Sheu, of Taipei Medical University Hospital. His team of researchers found that almost 3,200 had been diagnosed with sudden deafness between 2000 and 2008. Comparison was made with other five people of same age and sex without hearing loss. Out of those 19,000 people in total, 240 had been diagnosed with sleep apnea before the episode of sudden deafness occurred. Read the rest of this entry

As the number of patients diagnosed with sleep apnea is increasing the costs related to the health insurance is also increasing exponentially. This skyrocketing of the insurer’s sleep apnea related costs has now compelled the insurance companies to change their health coverage policies for the disorder.

A sleep apnea diagnosis usually requires patients undergo tests overnight in a sleep lab; some patients spend two nights in the lab to separately test for sleep apnea and to try a continuous positive airway pressure (CPAP) machine. Insurers often spend $1,900 for one overnight stay.

As a result of this increased spending, some experts are concerned that overnight tests to diagnose apnea are over-prescribed. Medicare payments for sleep testing increased from $62 million in 2001 to $235 million in 2009.

This contrasts effective home sleep tests that cost less than a fifth of the lab version. Although Medicare began paying for home sleep tests in 2008, the tests have had only modest growth. Read the rest of this entry

Verizon Wireless and NovaSom, Inc., the leader in obstructive sleep apnea (OSA) home testing, will be showcasing the NovaSom’s AccuSom  Home Sleep Test at 2012 International Consumer Electronics Show (CES), [the Verizon booth ,Las Vegas Convention Center, South Hall, Booth #30259].

The AccuSom Home Sleep Test is used in the diagnosis of obstructive sleep apnea(OSA), one of the most serious and under-diagnosed medical conditions in the United States, affecting nearly 18 million Americans.  AccuSom is the only FDA-cleared wireless home sleep test on the market, utilizing Verizon’s network to wirelessly collect and transfer sleep data from the patient’s home to a proprietary cloud-based sleep apnea management platform for physician interpretation and diagnosis. Read the rest of this entry

UT Arlington bioengineering researchers have designed an innovative, ultrasonic sensor system that can accurately detect whether a person suffers from sleep apnea without the inconvenience or cost associated with an overnight stay in a sleep center.

The University of Texas at Arlington has applied for a provisional patent for the concept and technology. Researchers are currently identifying private partners to market the device. UT Arlington has formed an alliance with Sleep Consultants Inc. in Fort Worth to conduct studies related to the research.

Sleep apnea affects an estimated 15 percent of adults nationwide. The chronic interruption of breathing can lead to hypertension, heart failure and even some brain injuries. The new detection system promises a speedier path to diagnosis and eventual relief, said Khosrow Behbehani, professor and chair of the UT Arlington Department of Bioengineering. Read the rest of this entry

Henry Schein Inc., the largest provider of health care products and services to office-based practitioners, today announced the launch of its Sleep Complete™ program, a new integrated comprehensive solution that provides all of the information and products necessary for the successful implementation of dental sleep medicine into the dental practice. A key component of this package will be Itamar-Medical’s WatchPAT home test device for the diagnosis of obstructive sleep apnea.The Sleep Complete package will be offered to dentists through a bundled financing package which should significantly lower the financial barrier to entry that often faces dentists interested in incorporating sleep medicine into their practice. Read the rest of this entry

NovaSom, Inc., the leader  in obstructive sleep apnea (OSA) home testing and cost-containment solutions, announces the launch of its next generation MediTrack(R) cloud-based CRM  application. The MediTrack OSA management platform is designed to enable custom  processing of payer-specific medical policy, billing, utilization management and  therapy coordination requirements to efficiently manage home sleep testing, OSA  diagnosis and recommended therapy.

NovaSom’s proprietary MediTrack system allows physicians to order a NovaSom  home sleep test online or by fax. The platform provides customizable information fields for easier physician entry of payer required data, leverages payer  communication preferences, and incorporates payer-specific messaging into patient shipping and handling and device return logistics. The system also manages rapid upload of patient sleep data for interpretation by a Board Certified physician, and then promptly publishes the OSA study results for secure online and fax delivery to the ordering physician. Upon positive diagnosis, the MediTrack technology integrates assignment of payer-preferred therapy providers. Read the rest of this entry

Bay Sleep, the West Coast’s largest and fastest growing independent sleep center, announced the opening of its newest, state-of-the-art sleep clinic in Oakland, California. Located one block from Summit Medical Center, this is Bay Sleep’s 16th clinic open for business.

Services include sleep physician consultations, diagnostic in-lab and home sleep testing and dispensing CPAP and other therapies for patients diagnosed with Obstructive Sleep Apnea (OSA) and other sleep disorders. Read the rest of this entry

Bam Labs aims to make health monitoring easier for people while they sleep. Notably, the company’s sensor is not wearable, but it tracks heart rate, breathing, and movement during sleep, and the company says it can even diagnose sleep apnea — all from a mattress pad located beneath the user.

The Bam Labs device was designed by former Apple employees. It is intended for use both in clinical settings and for home health.

The device functions through a sensor “at one corner of the pad. Air-pressure fluctuations caused by the tiny tremors caused by heartbeats or the more sizable shaking that occurs when someone turns over or gets out of bed are measured and controlled. Read the rest of this entry

According to the National Institute of Neurological Disorders and Strokes,  Sleep Apnea remains a growing health concern with an estimated 18 million  Americans suffering.  Sleep Group Solutions offers home sleep testing (HST)  devices (and interpretation), which have become a popular way to allow the  sufferer to get tested in the privacy of their own home, no over night stay in a  sleep lab needed.  The results are easily uploaded by the physician/practitioner  to InterpStudies.com for a quick diagnosis  of OSA (Obstructive Sleep Apnea).

Historically, an overnight sleep study in a sleep lab was the only way to  obtain a diagnosis of OSA (Obstructive Sleep Apnea).  Recent advancements in  technology has made its way directly into the consumers hands, creating an  increase in sleep apnea diagnosis.  Read the rest of this entry

Sleep Group Solutions (SGS), a leader in dental sleep medicine continuing education and sleep apnea (OSA) screening technology is launching a sleep study club, like no other.  Sleep Group Solutions has revolutionized the sleep industry by incorporating top level education, client support, innovating technologies, and now, a common ground to set the bar high in dental offices across the globe.

Dr. Michael Hnat, a dentist in Pittsburgh has been screening and treating his patients for sleep apnea for the past 4 years.  As a dentist, Dr. Hnat feels the airway is his responsibility, and each patient gets an evaluation, whether they know it or not.  “We screen each patient with forms, and a visual exam.  If the neck, tongue, or even BMI is larger than average, it’s a red flag.”  says Dr. Hnat.  After obtaining many successful cases, Dr. Hnat is a leader in his community in the fight against OSA.  When approached by Sleep Group Solutions to lead a study club in his state, Dr. Hnat was  excited to even the playing field. Read the rest of this entry

Impaired brachial flow-mediated dilation (FMD) is associated with risk for subsequent cardiovascular events in patients after myocardial infarction (MI). These patients often have obstructive sleep apnea (OSA). We tested the hypothesis that patients with OSA post MI will exhibit more severe impairment in FMD.

Sleep apnea testing generally requires an overnight stay in a sleep clinic, tens of wires attached to your head and body (glued), and tubes inserted into your nose and in front of your mouth. This setup makes for a difficult sleep on top of existing abnormalities, and, because the clinics need to be staffed all night, is relatively expensive.

Watermark Medical, out of Boca Raton, Florida, provides at home diagnostic solutions for sleep disorders such as sleep apnea by giving patients a headset, of sorts, to wear at home during sleep. Their device, the ARES Unicoder, collects O2 saturation, nasal airflow, pulse rate, snoring, head movement, and REM/NREM via an EEG. This data is combined with clinical indicators to provide an apnea index and respiratory disturbance index that allows physicians to diagnose sleep apnea.

The product, named by the Cleveland Clinic as a top 10 medical innovation of 2010, is being marketed as a reimbursable, less expensive alternative to in-lab sleep apnea testing.

A new computer screening tool developed and patented by a UB physician is helping to detect severe obstructive sleep apnea in cardiovascular patients who have not yet been diagnosed with this common and potentially dangerous condition.

The study, funded by the U.S. Department of Veterans Affairs, is being conducted by a UB researcher at the Veterans Affairs Western New York Healthcare System.

The goal is to evaluate how well the computer screening tool developed at UB diagnoses sleep apnea in patients with heart disease, compared to an overnight sleep study, or polysomnography, considered the ‘gold standard’ for diagnosing sleep apnea.

“The importance of this grant is that it may give us a faster way to screen for sleep apnea in patients who are already at high risk but who are undiagnosed,” says principal investigator Ali A. El Solh, professor of medicine, School of Medicine and Biomedical Sciences, and professor of social and preventive medicine, School of Public Health and Health Professions. Read the rest of this entry

Sleep apnea is a disorder that results from interrupted breathing during sleep. Indicators of this condition are snoring and tiredness despite getting a full night’s rest.

Sleep apnea does not immediately present itself as a serious problem, but it may cause heart problems and other health complications. Because of this, it is important to seek treatment for sleep apnea.

The term “sleep apnea” is an umbrella term that can refer to different versions of the disorder. As a result, treatment for sleep apnea can vary from patient to patient. Treatment methods include continuous positive airway pressure, adjustable airway pressure devices, oral appliances, supplemental oxygen bi-level positive airway pressure, and adaptive servo-ventilation—to name a few. In severe cases, surgery may be necessary.

When diagnosing or treating sleep apnea, your doctor may first recommend some lifestyle changes before prescribing medication. Some helpful lifestyle changes, such as quitting smoking and losing weight, are effective treatments.

Information on other at-home treatments, such as changing sleeping positions, are also helpful. However, be sure to consult your doctor first.